Growable Shunt as Novel Therapy in Children Requiring Aortopulmonary Shunt for Extended Time

Alexander P Bruno1, Daniel K Ragheb1, Dana R Janssen2

  • 1Vanderbilt University School of Medicine, Nashville, Tennessee.

Insights

A novel stent-restricted aortopulmonary shunt offers a safe, expandable solution for complex congenital heart defects, potentially avoiding repeat surgeries in pediatric patients.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Biomedical Engineering

Background:

  • Complex congenital heart defects (CHDs) often require palliative surgical interventions.
  • Double-inlet left ventricle presents significant surgical challenges.
  • Aortopulmonary shunts are crucial for palliation but can face occlusion or growth limitations.

Observation:

  • A 35-month-old girl with double-inlet left ventricle and an occluded ductal stent presented for surgical management.
  • Pulmonary artery unifocalization and central shunt placement were performed.
  • A novel stent-restricted aortopulmonary shunt was utilized anticipating prolonged shunt function.

Findings:

  • The stent-restricted shunt was designed to accommodate somatic growth, extending shunt longevity.
  • This technique allowed for shunt dilation without requiring repeat open surgical procedures.
  • The novel approach demonstrated safety and feasibility in a pediatric patient with complex CHD.

Implications:

  • This expandable shunt technique may reduce the need for reoperations in pediatric CHD patients.
  • It offers a promising strategy for managing aortopulmonary shunts in growing children.
  • This innovation could improve long-term outcomes for patients with complex single-ventricle physiology.